In addition to immune dysregulation, the loss of muscle mass suggests that the activins are potentially involved in the pathogenesis of CFS/ME, given the prominence of muscle weakness and pain as diagnostic criteria across the various case definitions. The gene discussed is INHBE; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.